Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Bauzon

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|October 30, 2003
A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38Hilde Stubdal, Noah Perin, Marilyn Lemmon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 24, 2023
Gla-domain mediated targeting of externalized phosphatidylserine for intracellular deliveryJonathan Hardy, Maxine Bauzon, Charles Kwok Fai Chan, et al.
Blood Advances|October 29, 2024
Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acidDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Blood Advances|February 3, 2023
Selective modulation of activated protein C activities by a nonactive site-targeting nanobody libraryDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Bioconjugate Chemistry|March 10, 2021
Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody-Drug ConjugatesStepan Chuprakov, Ayodele O Ogunkoya, Robyn M Barfield, et al.
Vaccines|March 30, 2023
Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer BiomarkersGloria I Perez, Matthew P Bernard, Daniel Vocelle, et al.
Molecular Therapy Oncolytics|May 9, 2017
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusSam Illingworth, Ying Di, Maxine Bauzon, et al.
Molecular Cancer Therapeutics|July 12, 2020
A Novel HER2-targeted Antibody-drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure LevelsRobyn M Barfield, Yun Cheol Kim, Stepan Chuprakov, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 13, 2006
Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based deliveryHarald Petry, Linda Cashion, Paul Szymanski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 5, 2019
Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100Carsten Alt, Shujun Yuan, Faye Wu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|October 30, 2003
A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38Hilde Stubdal, Noah Perin, Marilyn Lemmon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 24, 2023
Gla-domain mediated targeting of externalized phosphatidylserine for intracellular deliveryJonathan Hardy, Maxine Bauzon, Charles Kwok Fai Chan, et al.
Blood Advances|October 29, 2024
Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acidDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Blood Advances|February 3, 2023
Selective modulation of activated protein C activities by a nonactive site-targeting nanobody libraryDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Bioconjugate Chemistry|March 10, 2021
Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody-Drug ConjugatesStepan Chuprakov, Ayodele O Ogunkoya, Robyn M Barfield, et al.
Vaccines|March 30, 2023
Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer BiomarkersGloria I Perez, Matthew P Bernard, Daniel Vocelle, et al.
Molecular Therapy Oncolytics|May 9, 2017
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusSam Illingworth, Ying Di, Maxine Bauzon, et al.
Molecular Cancer Therapeutics|July 12, 2020
A Novel HER2-targeted Antibody-drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure LevelsRobyn M Barfield, Yun Cheol Kim, Stepan Chuprakov, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 13, 2006
Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based deliveryHarald Petry, Linda Cashion, Paul Szymanski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 5, 2019
Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100Carsten Alt, Shujun Yuan, Faye Wu, et al.
Pageof 3